| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |